[DOI] [PubMed] [Google Scholar] 155.Le Roy T., Llopis M., Lepage P., Bruneau A., Rabot S., Bevilacqua C., Martin P., Philippe C., Walker F., Bado A., et al
GLP-1 medications are capable of changing the way the digestive system works
While ok in the short term, long term, significant nutrient, protein and calorie intake puts you at higher risk of certain conditions, including bone loss (osteoporosis), a compromised immune system, hair loss, compromised cell health, nutrient deficiencies, weakness & fatigue, hormonal imbalances, cognitive impairment and sleep disturbances
It is emerging as a novel medication for the treatment of obesity
Orforglipron, an oral Small-Molecule GLP-1 receptor agonist, in early type 2 diabetes
Effects of food intake and body weight on a serotonergic turnover index in rat hypothalamus